€1.96
0.00% yesterday
Xetra, Jul 21, 05:36 pm CET
ISIN
DE000A3H2101
Symbol
AAQ1
Index
Sector

Aap Implantate Stock price

€1.96
+0.48 32.43% 1M
+0.14 7.69% 6M
+0.69 54.33% YTD
+0.66 50.77% 1Y
-0.80 28.99% 3Y
-1.68 46.15% 5Y
-21.34 91.59% 10Y
-14.94 88.40% 20Y
Xetra, Closing price Mon, Jul 21 2025
+0.00 0.00%
ISIN
DE000A3H2101
Symbol
AAQ1
Index
Sector

Key metrics

Basic
Market capitalization
€27.3m
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
- | negative
P/S
2.9 | 1.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
66.1%
Return on Equity
-34.7%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
€9.5m | €15.3m
EBITDA
- | €1.1m
EBIT
€2.3m | €-204.0k
Net Income
€2.2m | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | 25.4%
EBITDA
- | 230.5%
EBIT
- | 92.5%
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | 7.3%
EBIT
24.4%
Net
23.0% | -
Free Cash Flow
-
More
EPS
-
FCF per Share
-
Short interest
-
Employees
87
Rev per Employee
€140.0k
Show more

Is Aap Implantate a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,010 stocks worldwide.

Aap Implantate Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Aap Implantate forecast:

3x Hold
33%
6x Sell
67%

Analyst Opinions

9 Analysts have issued a Aap Implantate forecast:

Hold
33%
Sell
67%

Financial data from Aap Implantate

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
9.53 9.53
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2.33 2.33
-
24%
Net Profit 2.20 2.20
-
23%

In millions EUR.

Don't miss a Thing! We will send you all news about Aap Implantate directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. It offers trauma and biomaterials products which include anatomical plating system LOCTEQ, cannulated screws, standard plates and screws, bone cements, and mixing systems. The company was founded by Uwe Ahrens in 1990 and is headquartered in Berlin, Germany.

Head office Germany
CEO Rubino Girolamo
Employees 87
Founded 1990
Website www.aap.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today